Most lately, it has been discovered that conolidine and the above derivatives act over the atypical chemokine receptor three (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to the big range of endogenous opioids. Contrary to most opioid receptors, this receptor acts being a scavenger and does not activate a next me